Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now


Shares of Eli Lilly (NYSE: LLY) are up by a shocking 309% over the last three years, and, as smart investors know, a lot of that gain is attributable to just two words. Both of those words are the names of the company's rising-star medicines.

And the projections for the future growth prompted by both of those medicines are likely to shock even the optimists. Here's why they make this stock worth a buy.

Lilly's revenue rose by 26% year over year in the first quarter, reaching more than $8.7 billion. The growth was driven by the two words that every investor in this stock should know by now: Mounjaro and Zepbound.

Continue reading


Source Fool.com

Like: 0
LLY
Share

Comments